Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New cardiovascular disease markers in patients with familial hypercholesterolemia carriers of genetic variants. | J Diabetes Metab Disord | 2025 | 39697859 | PubTator, text mining | PubMed |
| Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer. | JTO Clin Res Rep | 2025 | 39619775 | PubTator, text mining | PubMed |
| Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients. | J Proteomics | 2025 | 39547396 | PubTator, text mining | PubMed |
| Metformin Exhibits Anti-Inflammatory Effects by Regulating microRNA-451/CXCL16 and B Cell Leukemia/Lymphoma 2 in Patients With Osteoarthritis. | ACR Open Rheumatol | 2025 | 39435687 | PubTator, text mining | PubMed |
| Plasma from type 1 diabetes patients promotes pro-atherogenic cholesterol transport in human macrophages. | J Investig Med | 2025 | 39417428 | PubTator, text mining | PubMed |
| LL37-DNA Complex Drives Vitiligo Progression Through TLR9-MyD88 Signaling Pathways. | Pigment Cell Melanoma Res | 2025 | 39344705 | PubTator, text mining | PubMed |
| Inhibition of Epidermal Isoleucyl-tRNA Synthetase Ameliorates Psoriasis-Like Skin Lesions through Jak2/Signal Transducer and Activator of Transcription 3/CXCL16 Signaling Pathway. | J Invest Dermatol | 2025 | 39293712 | PubTator, text mining | PubMed |
| WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma | Curr Cancer Drug Targets | 2025 | 37641996 | PubTator, text mining | PubMed |
| Efficacy of butylphthalein injection combined with alteplase thrombolysis in patients with acute cerebral infarction and its impact on Lp-PLA2 and CXCL16 levels. | Am J Transl Res | 2024 | 39822495 | PubTator, text mining | PubMed |
| CXCL16 promotes proliferation of head and neck squamous cell carcinoma by regulating GPX1-mediated antioxidant levels. | J Zhejiang Univ Sci B | 2024 | 39815613 | PubTator, text mining | PubMed |
| Effects of PGK1 on immunoinfiltration by integrated single-cell and bulk RNA-sequencing analysis in sepsis. | Front Immunol | 2024 | 39712033 | PubTator, text mining | PubMed |
| Exploring the Role of Chemokine-Related Gene Deregulation and Immune Infiltration in Ischemic Stroke: Insights into CXCL16 and SEMA3E as Potential Biomarkers. | J Mol Neurosci | 2024 | 39663269 | PubTator, text mining | PubMed |
| Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment. | Arch Pharm Res | 2024 | 39607647 | PubTator, text mining | PubMed |
| CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer. | Front Oncol | 2024 | 39588301 | PubTator, text mining | PubMed |
| Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals. | J Transl Med | 2024 | 39587670 | PubTator, text mining | PubMed |
| Exploring mesenchymal stem cells homing mechanisms and improvement strategies. | Stem Cells Transl Med | 2024 | 39550211 | PubTator, text mining | PubMed |
| Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6+ cells. | Infect Immun | 2024 | 39436058 | PubTator, text mining | PubMed |
| CD8 positive T-cells decrease neurogenesis and induce anxiety-like behaviour following hepatitis B vaccination. | Brain Commun | 2024 | 39386089 | PubTator, text mining | PubMed |
| Reply: Regarding the Predictive Role of CXCL16 in Liver Inflammation in Chronic Hepatitis B Patients. | J Viral Hepat | 2024 | 39367665 | PubTator, text mining | PubMed |
| Proinflammatory immune cells disrupt angiogenesis and promote germinal matrix hemorrhage in prenatal human brain. | Nat Neurosci | 2024 | 39349662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=11